TABLE 4.
Control subjects | First-degree relatives | Diabetic patients | |
---|---|---|---|
State 3 on malate + glutamate + succinate | 53.8 ± 5.7 | 46.1 ± 4.8 | 35.1 ± 1.7* |
State 4 | 23.0 ± 2.1 | 20.1 ± 2.0 | 20.8 ± 1.6 |
State u | 105.8 ± 9.5 | 77.5 ± 11.4 | 72.8 ± 6.9* |
State 3 on malate + palmitoyl-carnitine + glutamate + succinate | 60.8 ± 6.9 | 55.5 ± 4.6 | 42.1 ± 2.8 |
State 4 | 34.4 ± 2.8 | 32.2 ± 4.3 | 28.6 ± 2.0 |
State u | 113.8 ± 14.4 | 80.2 ± 6.4 | 88.8 ± 9.9 |
Data are means ± SE and are pmol/(s*mg)/(mtDNA copy numbers × 10,000).
P < 0.05 diabetic patients vs. control subjects.